Intelligent Emboli Removal Systems
Legal Citation
Summary of the Inventive Concept
Next-generation catheter-based emboli removal devices integrating AI, machine learning, and advanced sensors for real-time navigation, adaptation, and optimization in various vascular applications.
Background and Problem Solved
The original patent's mechanical thrombectomy devices, while effective, have limitations in terms of adaptability to changing vessel conditions, clot types, and patient anatomy. The new inventive concept addresses these limitations by incorporating advanced technologies to improve efficacy, safety, and procedural efficiency.
Detailed Description of the Inventive Concept
The intelligent emboli removal systems comprise catheter-based devices with integrated AI-powered navigation systems, shape-memory alloy components, modular designs, and advanced sensors such as ultrasound transducers. These systems can detect and adapt to changing vessel conditions in real-time, conform to unique patient anatomy, and predict and prevent distal complications. The devices can be tailored to specific vascular applications, including neurocranial emboli removal, deep vein thrombosis treatment, and pulmonary embolism treatment.
Novelty and Inventive Step
The integration of AI, machine learning, and advanced sensors in catheter-based emboli removal devices constitutes a significant departure from the original patent's mechanical thrombectomy devices. The new claims introduce a paradigm shift in the field, enabling real-time adaptation and optimization in various vascular applications.
Alternative Embodiments and Variations
Alternative embodiments may include the use of other advanced materials, such as nanomaterials or bioresorbable materials, or the integration of additional sensors, such as optical coherence tomography or intravascular ultrasound. Variations may include the development of robotic-assisted systems or the use of swarm intelligence to optimize emboli removal.
Potential Commercial Applications and Market
The intelligent emboli removal systems have significant commercial potential in various industries, including medical device manufacturing, healthcare services, and pharmaceuticals. The target markets include hospitals, clinics, and medical research institutions, with potential applications in cardiology, neurology, and vascular surgery.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61B17/22012 |
| A | A61 | A61B17/221 |
| A | A61 | A61B2017/22038 |
| A | A61 | A61B2017/22084 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Interventional medical devices, specifically catheter-based embolic capture and removal systems for vascular interventions, with expertise in device design, materials science, and minimally invasive surgical techniques
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or interventional medical device designer with advanced degrees in bioengineering, experience in medical device development, knowledge of vascular anatomy, and familiarity with emerging medical technologies
Obviousness Rationale
A person having ordinary skill would recognize that integrating AI, advanced sensors, and adaptive materials into existing embolic capture device designs represents a predictable technological evolution. The source patent's fundamental mechanical thrombectomy device provides a clear technological foundation that a skilled practitioner would naturally seek to enhance with emerging computational and materials technologies. The PTD's variations represent incremental improvements that leverage known technological capabilities in medical device design.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,209 |
|---|---|
| Title | Devices and methods for treating blocked blood vessels |
| Assignee(s) | SHANGHAI WALLABY MEDICAL TECHNOLOGIES CO., INC. |